genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Artificial Intelligence

      One AI Tool Bests Another in Enzyme Prediction Match

      Cancer

      How Incurable Melanoma Resists Treatment

      Rodeo
      AgBio

      Food For Thought: Final Report from the AGBT Ag Meeting

      Cancer

      Molecular Time Travel Helps Colon Cells Turn Cancerous

      Autism, puzzle pieces and brain
      Autism

      Amino Acid Deficit Impacts Perinatal Mouse Brain Development, Leading to Microcephaly,…

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Base Editing

      One-Time Treatment: Base Editing Shows Promise vs. SMA

      Drug Delivery

      Nature’s Needle: Feng Zhang’s Team Re-engineers Bacterial “Syringes” for Programmable Protein…

      Bioprocessing

      Polymer Formulation to Improve Existing Antibiotics

      Bioprocessing

      Key Consideration for Going Digital

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home Companies Takeda

Takeda

  • 23andMe
  • Abbvie
  • AdnaGen
  • Agilent Technologies
  • Alexion Pharmaceuticals
  • Amgen
  • Astellas
  • AstraZeneca
  • Audentes Therapeutics
  • Berkeley Lights
  • Bio-Rad Laboratories
  • Biogen
  • Cancer Genetics
  • Catalent
  • Charles RIver Laboratories
  • Dana-Farber Cancer Institute
  • deCODE genetics
  • Dicerna
  • Dimension Therapeutics
  • Exact Sciences
  • Foundation Medicine
  • GE Healthcare
  • GeneInsight
  • Gilead Sciences
  • GlaxoSmithKline
  • Halozyme Therapeutics
  • Hitachi High-Technologies
  • Horizon Discovery Group
  • Human Longevity
  • Illumina
  • Jackson Laboratory
  • Janssen Biotech
  • LabCorp
  • Maravai LifeSciences
  • MD Anderson
  • MDxHealth
  • MedImmune
  • Memorial Sloan Kettering Cancer Center
  • Merck & Co
  • Merck KGaA
  • NanoString Technologies
  • Novartis
  • Pathology
  • PerkinElmer
  • PersonalizeDx
  • Qiagen
  • RayBiotech
  • Roche
  • Sanofi
  • shire
  • Sigma-Aldrich
  • Synthego
  • Takeda
  • Thermo Fisher Scientific
  • UCB Biosciences
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Blood Disorders

    Rising Star: Vega Targets Rare Blood Disorders with Antibodies

    Autoimmune Disorders

    Takeda Acquires Autoimmune Candidate from Nimbus for Up to $6B

    DNA molecule, illustration
    Takeda

    With Up-to-$3.6B Poseida Collaboration, Takeda Doubles Down on Gene Therapy

    Takeda

    Anima Biotech Heads for the Light with Up-to-$2.4B Takeda Partnership

    Takeda

    Sangamo CEO Ponders Pipeline, Reflects on Phase III ‘Proud Moment’

    Takeda

    Takeda, Neurocrine Biosciences Launch up to $2B+ CNS Collaboration

    Coronavirus
    Takeda

    Coronavirus: Takeda Pursues Plasma-Derived Treatment; Alnylam and Vir Eye siRNA Therapy

    Takeda

    Takeda Licenses COUR’s Celiac Disease Candidate after Successful Phase IIa Trial

    Takeda

    Takeda, Sosei Heptares Launch Up-to-$1.2B Collaboration Targeting Gastrointestinal GPCRs

    handshake
    Takeda

    Takeda Sells Two Drugs for $5.7B+, Licenses a Third, in Deals...

    Takeda

    Takeda Inks Licensing Option Agreement with Gene Editing Platform Developer Emendo

    Business meeting
    Takeda

    Shire, Takeda Shareholders Approve $58.5B Acquisition Deal

    Takeda

    Shire, Takeda Come to Terms on $62B Acquisition Deal

    Takeda

    Shire Board Sets Stage for $64B Takeda Acquisition, If Companies Resolve...

    Takeda

    Shire Rejects Takeda Takeover Bids

    123Page 1 of 3

    Recently Featured

    One AI Tool Bests Another in Enzyme Prediction Match

    One AI Tool Bests Another in Enzyme Prediction Match

    One-Time Treatment: Base Editing Shows Promise vs. SMA

    One-Time Treatment: Base Editing Shows Promise vs. SMA

    Food For Thought: Final Report from the AGBT Ag Meeting

    Food For Thought: Final Report from the AGBT Ag Meeting

    Molecular Time Travel Helps Colon Cells Turn Cancerous

    Molecular Time Travel Helps Colon Cells Turn Cancerous

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up